About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Seattle | 545 Studies

Clinical Trials Breast CancerSeattle

Breast Cancer Clinical Trials in Seattle

Find 545 clinical trials for breast cancer near Seattle, Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 545 trials

CompletedA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsIn this four-part study, NKTR-214 was administered in combination with nivolumab and with/without other anticancer therapies.NCT02983045·La Jolla, California and 57 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedGenetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung CancerThis phase I/II trial investigates the side effects of genetically engineered cells called FH-MagIC TCR-T cells and how well they work with atezolizumab in treating patients with…NCT04639245·Seattle, Washington

RecruitingBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadThis study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery.NCT06324357·Cerritos, California and 103 others

Active not recruitingNiraparib + Dostarlimab In BRCA Mutated Breast CancerThis research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PALB2 mutations.NCT04584255·New Haven, Connecticut and 7 others

CompletedTaxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerThe two drugs used to treat metastatic breast cancer in this study may perform better when used together than when used separately.NCT00194740·Seattle, Washington

CompletedVitamin D, Diet and Activity StudyExperimental and human data suggests that vitamin D could protect against breast cancer. Overweight/obese individuals are at increased risk of low vitamin D levels.NCT01240213·Seattle, Washington

CompletedA Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid TumorsThe purpose of this study is to evaluate the tolerability and safety profile of ASP1948 when administered as a single agent and in combination with nivolumab or pembrolizumab in…NCT03565445·New Haven, Connecticut and 41 others

CompletedSurgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast CancerRATIONALE: Removing the sentinel lymph nodes and examining them under a microscope may help plan more effective surgery for breast cancer.NCT00003830·Mobile, Alabama and 77 others

RecruitingA Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsA Study of Emi-Le in Participants with Solid TumorsNCT05377996·Phoenix, Arizona and 25 others

RecruitingASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerThe Substudy Protocol ASPEN-09-03 is a Phase 2, single-arm, multicenter study evaluating the efficacy, safety, and tolerability of evorpacept in combination with trastuzumab and…NCT07007559·Phoenix, Arizona and 60 others

CompletedRadiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyThis randomized phase III trial studies radiation therapy to see how well it works with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone…NCT00769379·Anniston, Alabama and 1259 others

Active not recruitingLow-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsEstrogen can cause the growth of breast cancer cells.NCT01196936·Birmingham, Alabama and 12 others

Active not recruitingDoxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerThis randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with…NCT02488967·Mobile, Alabama and 1295 others

CompletedEarly Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerRATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of…NCT01242800·Mobile, Alabama and 376 others

CompletedZoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal TherapyThis protocol is designed to compare the effect on bone of Zoledronic Acid 4 mg every 6 months when given upfront versus delayed start (based on a post-baseline BMD T- Score below…NCT00050011·Springdale, Arkansas and 43 others

CompletedA Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast CancerThis study is to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast cancer (MBC).NCT04699630·Birmingham, Alabama and 10 others

CompletedA Safety Study of SGN-LIV1A in Breast Cancer PatientsThis study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer.NCT01969643·Birmingham, Alabama and 37 others

CompletedEducational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer PatientsThis randomized clinical trial studies educational counseling in improving communication and quality of life in spouses and breast cancer patients.NCT01723943·Seattle, Washington

Active not recruitingSurgery in Preventing Ovarian Cancer in Patients With Genetic MutationsThis phase II trial studies how well surgery works in preventing ovarian cancer in patients with genetic mutations at risk of ovarian cancer.NCT02760849·Chicago, Illinois and 8 others

RecruitingA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsThis is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors.NCT06172478·Duarte, California and 95 others

PreviousPage 16 of 28Next

Other Conditions in Seattle

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma